The company revolutionizing early Alzheimer’s detection
Neurosteer’s high-tech EEG brain scan enables a fast, automatic, music-driven, audio-guided test people can take during their annual medical checkup.
Neurosteer’s high-tech EEG brain scan enables a fast, automatic, music-driven, audio-guided test people can take during their annual medical checkup.
Regional Medicare contractors in 13 states approve reimbursement for a clinically validated virtual reality training intervention from GaitBetter.
By combining software with traditional pharmaceuticals, Remepy’s hybrid drugs promise personalized and more effective treatments for cancer, Parkinson’s and more.
The discovery and research of a newly-found link between the brain’s structure and Parkinson’s could advance efforts to find a cure.
Phase III studies of Pharma Two B’s once-daily pill delivers the best aspects of two existing drugs for superior efficacy and safety.
Bionaut Labs CEO says in the future illnesses that now seem incurable will be treated by medication delivered straight to the affected organ.
Study from University of Haifa identifies common neural processes of Parkinson’s disease types for the first time; could aid early diagnosis.
New qMRI analytic method from Hebrew University reveals cellular changes in the microstructures of the brain area affected by Parkinson’s disease.